SBC Medical Group Holdings Incorporated (SBC)
SBC trades on Nasdaq in Health Care, Medical/Nursing Services. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price, change, market cap, sector and industry: Nasdaq stock screener, as of November 16, 2026. Revenue: SEC 10-K (us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax), fiscal year ended 2025-12-31, https://www.sec.gov/Archives/edgar/data/1930313/000119312526127557/0001193125-26-127557-index.htm. Net income: SEC 10-K (us-gaap:NetIncomeLoss), fiscal year ended 2025-12-31.
Profile
| Field | Value |
|---|---|
| Ticker | SBC on Nasdaq |
| Sector | Health Care |
| Industry | Medical/Nursing Services |
| Country | United States |
| IPO year | 2022 |
| SEC CIK | 0001930313 |
| SEC industry code | Services-Offices & Clinics of Doctors of Medicine |
| Incorporated in | DE |
Financials · 2025
| Line | Value |
|---|---|
| Revenue | $173.6M |
| Net income | $51.0M |
| Operating income | $67.5M |
| Net margin | 29.4% |
| Operating margin | 38.9% |
| Revenue growth | -15.5% |
| Cash | $163.8M |
| Total assets | $380.4M |
| P/E (computed) | 12.5× |
| P/S (computed) | 3.7× |
Warning signs
| Sign | Finding | Source |
|---|---|---|
| Going concern | No going-concern finding. | 10-Q 2026-11-13 |
| Cash and burn | $198.4M cash; operating cash flow $25.6M a quarter. | Report 2026-09-30 |
| Shares outstanding | 102,846,943 (2026-10-31); 102,576,943 a year earlier. | Cover page 2026-10-31 |
| Reverse splits, 3 years | None found | None on EDGAR |
| Shelf and offerings, 12 months | 1 S-3/F-3 shelf filings; 0 424B5 takedowns | Latest 2025-12-29 |
| Exchange deficiency notices, 12 months | None | None on EDGAR |
| Auditor | MaloneBailey, LLP, Tokyo, Japan | PCAOB Form AP 2026-04-08 |
| Late filings, 12 months | None | None on EDGAR |
| Insider trades, 12 months | Bought $0, sold $20.1M on the open market | SEC Forms 3/4/5 data sets 2026-09-30 |
From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.
Quarterly results
| Quarter | Revenue | Net income | Op. cash flow | Cash | Total debt | TTM revenue | Source |
|---|---|---|---|---|---|---|---|
| Q3 2026 2026-09-30 | $58.6M | $15.7M | $18.5M | $198.4M | $33.6M | $190.4M | 10-Q 2026-11-13 |
| Q2 2026 2026-06-30 | $49.2M | $10.7M | $22.5M | $184.3M | $37.8M | $175.2M | 10-Q 2026-08-13 |
| Q1 2026 2026-03-31 | $43.1M | $11.3M | $9.2M | $167.3M | $40.4M | $169.3M | 10-Q 2026-05-14 |
| Q4 2025 2025-12-31 | $39.6M | $14.2M | $52.0M | $163.8M | $42.8M | $173.6M | 10-K 2026-03-27 |
| Q3 2025 2025-09-30 | $43.4M | $12.8M | -$20.9M | $127.4M | $21.1M | $178.5M | 10-Q 2026-11-13 |
| Q2 2025 2025-06-30 | $43.4M | $2.5M | -$8.3M | $152.7M | $7.1M | $188.2M | 10-Q 2026-08-13 |
| Q1 2025 2025-03-31 | $47.3M | $21.5M | $1.9M | $132.1M | $6.9M | $197.9M | 10-Q 2026-05-14 |
| Q4 2024 2024-12-31 | $44.4M | $6.5M | -$7.3M | $125.0M | $6.6M | $205.4M | 10-K 2026-03-27 |
From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document | 424B7 | 2026-04-20 |
| Latest annual report | 10-K/A | 2026-04-30 |
| Latest quarterly / interim | 10-Q | 2026-11-13 |
| Latest current report | 8-K | 2026-11-13 |
| Latest proxy | DEFA14A | 2026-05-28 |
Source: SEC EDGAR submissions feed, 234 recent filings. All filings on EDGAR.
Price moves
| Window | Return |
|---|---|
| 1 week | +45.8% |
| 1 month | +38.2% |
| 3 months | +130.4% |
| Year to date | +70.5% |
| 1 year | +118.8% |
| From 52-week high | 0.0% |
Source: Yahoo Finance daily closes, last bar 2026-11-13. Computed by MarginsX from daily closes; cap, sector and tier from the Nasdaq screener.
Other listings for this company
| Ticker | Name | Price |
|---|---|---|
| SBCWW | SBC Medical Group Holdings Incorporated Warrants | $0.7975 |
Peers in Medical/Nursing Services
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| SRTA | Strata Critical Medical Inc. | $5.42 | -1.63% | $484.1M |
| OMDA | Omada Health Inc. | $14.49 | +1.12% | $898.9M |
| AHCO | AdaptHealth Corp. | $7.73 | +0.91% | $1.1B |
| STLN | Starling Oncology Inc. | $3.54 | +1.14% | $361.0M |
| AUNA | Auna SA | $4.63 | +0.87% | $342.7M |
| PNTG | The Pennant Group Inc. Common Stock | $37.03 | +2.66% | $1.3B |
| INNV | InnovAge Holding Corp. | $9.58 | +1.16% | $1.3B |
| USPH | U.S. Physical Therapy Inc. | $99.55 | +0.41% | $1.5B |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier